Valuation: CeriBell, Inc.

Market Cap 901M 804M 749M 681M 1.28B 87.21B 1.29B 8.99B 3.52B 44.45B 3.38B 3.31B 142B P/E 2026 *
-11.7x
P/E 2027 * -14.4x
Enterprise Value 906M 808M 753M 685M 1.29B 87.68B 1.3B 9.04B 3.54B 44.68B 3.4B 3.33B 143B EV / Sales 2026 *
7.85x
EV / Sales 2027 * 6.33x
Free-Float
88.16%
Yield 2026 *
-
Yield 2027 * -
1 day-1.41%
1 week-5.08%
Current month-5.08%
1 month-6.35%
3 months+16.62%
6 months+29.55%
Current year+5.56%
1 week 22.62
Extreme 22.62
25.1
1 month 22.62
Extreme 22.62
25.63
Current year 15.84
Extreme 15.84
25.63
1 year 10.85
Extreme 10.85
25.63
3 years 10.01
Extreme 10.01
32.75
5 years 10.01
Extreme 10.01
32.75
10 years 10.01
Extreme 10.01
32.75
Manager TitleAgeSince
Chief Executive Officer 46 01/10/2015
Director of Finance/CFO 44 01/04/2020
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 46 29/08/2014
Chairman 57 29/08/2014
Director/Board Member 64 01/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
01/10/26 Exercice

Chief Technology Officer

14,661 0.0382%
15/09/26 Exercice

Chief Financial Officer

2,538 0.0066%
15/09/26 Sell

Founder

-20,846 0.0543%
Change 5-day change 1-year change 3-year change Capi.($)
-1.41%-5.08%+96.19% - 901M
-1.52%-3.42%+20.92%+30.78% 245B
-0.47%-1.85%+4.16%+0.11% 154B
+0.21%+2.16%-5.79%+40.49% 146B
+1.11%-3.69%-56.16%-19.34% 60.26B
-1.80%-2.41%+9.80%+14.30% 49.44B
-0.54%-2.40%+21.37%+52.00% 47.67B
-0.78%+0.76%-21.16%-19.35% 48.04B
+0.83%-0.21%-6.98%+35.90% 45.74B
-1.57%-2.34%+34.80%+60.48% 42.84B
Average -0.72%-1.93%+9.71%+21.71% 83.97B
Weighted average by Cap. -0.85%-2.10%+3.90%+22.42%

Financials

2026 *2027 *
Net sales 115M 103M 96.01M 87.29M 164M 11.18B 166M 1.15B 451M 5.7B 433M 424M 18.24B 147M 131M 122M 111M 209M 14.23B 211M 1.47B 574M 7.25B 552M 540M 23.23B
Net income -75.94M -67.73M -63.14M -57.4M -108M -7.35B -109M -757M -296M -3.75B -285M -279M -11.99B -64M -57.08M -53.21M -48.37M -91.02M -6.19B -91.96M -638M -250M -3.16B -240M -235M -10.11B
Net Debt 4.85M 4.32M 4.03M 3.66M 6.89M 469M 6.96M 48.34M 18.91M 239M 18.19M 17.8M 765M 29.76M 26.54M 24.74M 22.49M 42.33M 2.88B 42.76M 297M 116M 1.47B 112M 109M 4.7B
Projected Income Statement - Annual - CeriBell, Inc.
Logo CeriBell, Inc.
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its hardware is composed of disposable, flexible headbands and head caps (Wearables) and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals. EEG data captured by the recorder are interpreted by its proprietary AI-powered seizure detection algorithms, which monitor the patient’s EEG signal and support the clinician’s real-time assessment of seizure activity.
Employees
327
Date Price Change Volume
08/10/26 $23.15 -1.41% 240,684
07/10/26 $23.48 -3.53% 305,400
06/10/26 $24.34 -2.09% 241,740
05/10/26 $24.86 +4.94% 239,505
02/10/26 $23.69 +0.34% 307,031
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Ratings Surperformance© - CeriBell, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
23.15USD
Average target price
28.57USD
Spread / Average Target
+23.42%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CeriBell, Inc.
  1. Stock Market
  2. Stocks
  3. CBLL Stock